Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
Sponsor: First Affiliated Hospital of Wenzhou Medical University
A PHASE2/PHASE3 clinical study on Hepatocellular Carcinoma and Pulmonary Metastasis, this trial is ongoing. The trial is conducted by First Affiliated Hospital of Wenzhou Medical University and has accumulated 8 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Dec 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE2_PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Wenzhou Medical University
- First Affiliated Hospital of Zhejiang University
- Ningbo No.2 Hospital
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- The Central Hospital of Lishui City
- Zhejiang Cancer Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.